MOPAX
Price
$25.74
Change
-$0.06 (-0.23%)
Updated
Aug 15 closing price
Net Assets
288.25M
VSCPX
Price
$340.19
Change
-$1.26 (-0.37%)
Updated
Aug 15 closing price
Net Assets
154.18B
Interact to see
Advertisement

MOPAX vs VSCPX

Header iconMOPAX vs VSCPX Comparison
Open Charts MOPAX vs VSCPXBanner chart's image
NYLI WMC Small Companies
Price$25.74
Change-$0.06 (-0.23%)
VolumeN/A
Net Assets288.25M
Vanguard Small Cap Index InstlPlus
Price$340.19
Change-$1.26 (-0.37%)
VolumeN/A
Net Assets154.18B
MOPAX vs VSCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MOPAX vs. VSCPX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOPAX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 154B vs. MOPAX (288M). VSCPX pays higher dividends than MOPAX: VSCPX (1.39) vs MOPAX (0.18). MOPAX was incepted earlier than VSCPX: MOPAX (22 years) vs VSCPX (15 years). MOPAX (1.21) is less costly to investors than VSCPX (0.03). MOPAX is a more actively managed with annual turnover of: 96.00 vs. VSCPX (13.00). MOPAX has a lower initial minimum investment than VSCPX: MOPAX (15000) vs VSCPX (100000000). VSCPX (9.18) and MOPAX (8.96) have marching annual gain over last year. VSCPX return over 5 years is better than : 57.76 vs. MOPAX (12.05).
MOPAXVSCPXMOPAX / VSCPX
Total Expense Ratio1.210.034,033%
Annual Report Gross Expense Ratio1.210.034,033%
Fund Existence22 years15 years-
Gain YTD1.1002.52844%
Front Load6%N/A-
Min. Initial Investment150001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets288M154B0%
Annual Yield % from dividends0.181.3913%
Returns for 1 year8.969.1898%
Returns for 3 years14.4920.5071%
Returns for 5 years12.0557.7621%
Returns for 10 years-2.39113.19-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
EWTX14.150.22
+1.58%
Edgewise Therapeutics
RYAN59.12-0.39
-0.66%
Ryan Specialty Holdings
MBINM25.19-0.18
-0.72%
Merchants Bancorp
ALT3.63-0.05
-1.36%
Altimmune